These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 22885229)

  • 1. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric micelles for oral drug delivery.
    Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
    Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
    Bunjes H
    J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
    Brough C; Williams RO
    Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
    Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
    Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
    Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
    J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
    Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW
    J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization.
    Sant VP; Smith D; Leroux JC
    J Control Release; 2004 Jun; 97(2):301-12. PubMed ID: 15196757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
    Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
    Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
    Alhnan MA; Murdan S; Basit AW
    Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.